WHO: Don’t Use Fluvoxamine for Treatment of COVID-19?

The World Health Organization (WHO) publishes online the &ldquo;The WHO Therapeutics and COVID-19: living guideline,&rdquo; which is the global health organization&rsquo;s most up-to-date recommendations for the use of therapeutics in the treatment of COVID-19. Most recently, they updated their latest version of living guidelines, now its 10th, which includes 19 recommendations including two new actions including fluvoxamine and colchicine. Even though both showed positive results in major clinical trials, both fluvoxamine and colchicine neither is recommended. WHO only recommends fluvoxamine for the use in clinical trials in patients with non-severe COVID-19 while they don&rsquo;t recommend colchicine use at all. 
What follows is a brief summary of the updates and a breakdown of what drugs WHO recommends, and some commentary along the way.